Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |